Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.
Single Cell Genomics offers vast opportunities in healthcare R&D, with potential for new disease identification and treatment. It's transitioning from lab to clinical settings, and as understanding of ...
StockStory.org on MSN
Q3 Earnings Highlights: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
Investing News Network on MSN
Biotech market forecast: Top trends for biotech in 2026
The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum ...
OverviewThe global NLP in healthcare & life sciences market is anticipated to expand at a CAGR of nearly 25% during the forecast period, fueled by widespread EHR adoption, rising interest in ...
Regtechtimes on MSN
Labro secures $1.5M to automate & streamline laboratory workflows
Biotech startup Labro Inc. has raised $1.5 million in seed funding to accelerate pilot deployments of its flagship automated ...
EBRD helps Lebanese biotech startup DLOC Biosystems advance its breakthrough drug testing technology
EBRD and European Union support DLOC Biosystems and the Lebanese American University Industrial Hub in collaboration to scale ...
Global Research Antibodies and Reagents Market OverviewThe global research antibodies and reagents market is expected to expand at a CAGR of 7% between 2025 and 2030, driven by the rising need for ...
Innovative approaches to making clinical studies more efficient and cost-effective were a central theme of the 2nd Annual COG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback